These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30583875)

  • 21. Lorazepam and diazepam for relieving catatonic features precipitated by initial hemodialysis in a uremic patient: a case report.
    Tsai MC; Huang TL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):423-4. PubMed ID: 20026370
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthetic marijuana use and development of catatonia in a 17-year-old male.
    Smith DL; Roberts C
    Minn Med; 2014 May; 97(5):38. PubMed ID: 24941587
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose.
    Balíková M
    Forensic Sci Int; 2005 Oct; 153(1):85-91. PubMed ID: 15979834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catatonia Due to Tacrolimus Toxicity 16 Years After Renal Transplantation: Case Report and Literature Review.
    Sikavi D; McMahon J; Fromson JA
    J Psychiatr Pract; 2019 Nov; 25(6):481-484. PubMed ID: 31821227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole.
    Huffman JC; Fricchione GL
    J Clin Psychopharmacol; 2005 Oct; 25(5):508-10. PubMed ID: 16160639
    [No Abstract]   [Full Text] [Related]  

  • 27. First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.
    Ovaska H; Viljoen A; Puchnarewicz M; Button J; Ramsey J; Holt DW; Dargan PI; Wood DM
    Eur J Emerg Med; 2008 Dec; 15(6):354-6. PubMed ID: 19078842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lorazepam withdrawal catatonia: a case report.
    Sivakumar T; Yadav A; Sood M; Khandelwal SK
    Asian J Psychiatr; 2013 Dec; 6(6):620-1. PubMed ID: 24309887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical predictors of response to treatment in catatonia.
    Narayanaswamy JC; Tibrewal P; Zutshi A; Srinivasaraju R; Math SB
    Gen Hosp Psychiatry; 2012; 34(3):312-6. PubMed ID: 22387048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome.
    Woodbury MM; Woodbury MA
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1161-4. PubMed ID: 1429421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lorazepam and diazepam for relieving catatonic features in multiple sclerosis.
    Hung YY; Huang TL
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1537-8. PubMed ID: 17640789
    [No Abstract]   [Full Text] [Related]  

  • 32. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy.
    Bush G; Fink M; Petrides G; Dowling F; Francis A
    Acta Psychiatr Scand; 1996 Feb; 93(2):137-43. PubMed ID: 8686484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could spice drugs induce psychosis with abnormal movements similar to catatonia?
    Haro G; Ripoll C; Ibáñez M; Orengo T; Liaño VM; Meneu E; Hernández F; Traver F
    Psychiatry; 2014; 77(2):206-8. PubMed ID: 24865202
    [No Abstract]   [Full Text] [Related]  

  • 34. α-Pyrrolidinopentiophenone ("Flakka") Catalyzing Catatonia: A Case Report and Literature Review.
    Richman EE; Skoller NJ; Fokum B; Burke BA; Hickerson CA; Cotes RO
    J Addict Med; 2018; 12(4):336-338. PubMed ID: 29533309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pitfalls in the treatment of jimsonweed intoxication.
    Shenoy RS
    Am J Psychiatry; 1994 Sep; 151(9):1396-7. PubMed ID: 8067503
    [No Abstract]   [Full Text] [Related]  

  • 36. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report.
    Rovasalo A; Tohmo H; Aantaa R; Kettunen E; Palojoki R
    Gen Hosp Psychiatry; 2006; 28(4):362-3. PubMed ID: 16814639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cavum septum pellucidum and cavum vergae with late-onset catatonia.
    Yasaki T; Takahashi Y; Takahashi T; Washizuka S; Amano N; Hanihara T
    J ECT; 2013 Sep; 29(3):e45-6. PubMed ID: 23670024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromo-DMA: the Australasian hallucinogen?
    Buhrich N; Morris G; Cook G
    Aust N Z J Psychiatry; 1983 Sep; 17(3):275-9. PubMed ID: 6580896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 40. Catatonia Due to Clozapine Withdrawal: A Case Report and Literature Review.
    Boazak M; Cotes RO; Potvin H; Decker AM; Schwartz AC
    Psychosomatics; 2019; 60(4):421-427. PubMed ID: 30268340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.